Brown J - Search Results

1

Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics.

Nelson DR, Brown J, Morikawa A, Method M. Nelson DR, et al. Among authors: brown j. PLoS One. 2022 Feb 25;17(2):e0264637. doi: 10.1371/journal.pone.0264637. eCollection 2022. PLoS One. 2022. PMID: 35213669 Free PMC article.

2

A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer.

Sheffield KM, Peachey JR, Method M, Grimes BR, Brown J, Saverno K, Sugihara T, Cui ZL, Lee KT. Sheffield KM, et al. Among authors: brown j. Future Oncol. 2022 Jul;18(21):2667-2682. doi: 10.2217/fon-2022-0310. Epub 2022 May 25. Future Oncol. 2022. PMID: 35611679 Free article.

3

A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States.

Brown J, Scardo S, Method M, Schlauch D, Misch A, Picard S, Hamilton E, Jones S, Burris H, Spigel D. Brown J, et al. BMC Cancer. 2022 May 6;22(1):502. doi: 10.1186/s12885-022-09557-6. BMC Cancer. 2022. PMID: 35524219 Free PMC article.

4

Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.

Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Davis KL, et al. Among authors: brown j. Lung Cancer. 2015 Feb;87(2):176-85. doi: 10.1016/j.lungcan.2014.11.002. Epub 2014 Nov 8. Lung Cancer. 2015. PMID: 25532680

5

The Budget Impact of Including Necitumumab on the Formulary for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer: U.S. Commercial Payer and Medicare Perspectives.

Bly CA, Molife C, Brown J, Tawney MK, Carter GC, Cinfio FN, Klein RW. Bly CA, et al. Among authors: brown j. J Manag Care Spec Pharm. 2018 Jun;24(6):534-543. doi: 10.18553/jmcp.2018.24.6.534. J Manag Care Spec Pharm. 2018. PMID: 29799326 Free PMC article.

6

The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial.

Reck M, Socinski MA, Luft A, Szczęsna A, Dediu M, Ramlau R, Losonczy G, Molinier O, Schumann C, Gralla RJ, Bonomi P, Brown J, Soldatenkova V, Chouaki N, Obasaju C, Peterson P, Thatcher N. Reck M, et al. Among authors: brown j. J Thorac Oncol. 2016 Jun;11(6):808-18. doi: 10.1016/j.jtho.2016.03.002. Epub 2016 Mar 12. J Thorac Oncol. 2016. PMID: 26980471 Free article. Clinical Trial.

7

Rash management and treatment persistence of cancer patients treated with epidermal growth factor receptor inhibitors in the Truven MarketScan^® research database.

Chen L, Brown J, Marmaduke DQ, Mayo C, Grau G, Lau YK, Obasaju CK. Chen L, et al. Among authors: brown j. Support Care Cancer. 2018 Jul;26(7):2369-2377. doi: 10.1007/s00520-018-4091-7. Epub 2018 Feb 8. Support Care Cancer. 2018. PMID: 29423677

8

Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer.

DeLozier AM, Brown J, Natanegara F, Zhao L, Cui ZL, Able SL, Bowman L, Treat J, Hess LM. DeLozier AM, et al. Among authors: brown j. Syst Rev. 2014 Sep 16;3:102. doi: 10.1186/2046-4053-3-102. Syst Rev. 2014. PMID: 25227571 Free PMC article.

9

Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.

Brown J, Liepa AM, Bapat B, Madhwani S, Lorenzen S, García-Foncillas J, Candrilli SD, Kaye JA. Brown J, et al. Eur J Cancer Care (Engl). 2020 Mar;29(2):e13213. doi: 10.1111/ecc.13213. Epub 2019 Dec 27. Eur J Cancer Care (Engl). 2020. PMID: 31883156

10

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.

Shabto JM, Martini DJ, Liu Y, Ravindranathan D, Brown J, Hitron EE, Russler GA, Caulfield S, Kissick H, Alemozaffar M, Ogan K, Harris WB, Master VA, Kucuk O, Carthon BC, Bilen MA. Shabto JM, et al. Among authors: brown j. Cancer Med. 2020 Apr;9(8):2752-2760. doi: 10.1002/cam4.2932. Epub 2020 Feb 25. Cancer Med. 2020. PMID: 32100417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,583 results

Search Page